Read twice and referred to the Committee on Commerce, Science, and Transportation. (text: CR S6834-3836)
The Management of Individuals’ Neural Data Act of 2025 (MIND Act) directs the Federal Trade Commission (FTC) to conduct a comprehensive study and produce a report within one year on governance, risks, and regulatory gaps related to neural data, neurotechnology, and related biometric/behavioral data. The FTC must consult multiple federal agencies and outside stakeholders and address topics including privacy, consent, AI integration, security, sector-specific risks (employment, education, law enforcement, marketing, etc.), and recommendations for categorization, enforcement, and incentives for ethical innovation.
Scope and speed: Liberals view the bill as a needed first step toward strong protections; conservatives worry it will enable executive overreach and hamper innovation.
Relative to its intended legislative type, this bill establishes a detailed and well-scoped mandate for a comprehensive FTC-led study and reporting process on neural data governance and creates a clear, timebound path to produce federal guidance that constrains agency procurement inconsistent with that guidance.
The Management of Individuals’ Neural Data Act of 2025 (MIND Act) directs the Federal Trade Commission (FTC) to conduct a comprehensive study and produce a report within one year on governance, risks, and regulatory gaps related to neural data, neurotechnology, and related biometric/behavioral data.
The FTC must consult multiple federal agencies and outside stakeholders and address topics including privacy, consent, AI integration, security, sector-specific risks (employment, education, law enforcement, marketing, etc.), and recommendations for categorization, enforcement, and incentives for ethical innovation.
The Act authorizes $10 million to carry out the study, requires annual updates, and directs the Director of OSTP, in consultation with FTC and OMB, to issue guidance for federal agencies on procurement and operational use of neurotechnology; OMB must then issue binding implementation guidance.
Judged solely on content, the bill is modest in fiscal terms, largely administrative and study‑oriented, and contains compromise‑friendly features (consultation, phased implementation, emphasis on recommendations). These features increase its chances compared with sweeping regulatory overhauls. Key obstacles are competing legislative priorities and any concentrated industry opposition to future regulatory implications; however, because the bill does not itself impose binding rules on the private sector and primarily directs federal agencies to study and develop guidance, it falls into a category that historically has a reasonable chance of passage if given committee and floor time.
Relative to its intended legislative type, this bill establishes a detailed and well-scoped mandate for a comprehensive FTC-led study and reporting process on neural data governance and creates a clear, timebound path to produce federal guidance that constrains agency procurement inconsistent with that guidance. The bill contains explicit definitions, a granular list of report elements, consultation requirements, publication and update obligations, and an express funding authorization for the study.
Scope and speed: Liberals view the bill as a needed first step toward strong protections; conservatives worry it will enable executive overreach and hamper innovation.
These are examples from the analysis, not a ranked list of the most-affected groups.
Scope and speed: Liberals view the bill as a needed first step toward strong protections; conservatives worry it will enable executive overreach and hamper innovation.
This persona is likely to view the bill positively as a necessary, precautionary step to address a fast-developing technology area with serious privacy, civil rights, and power-concentration concerns.
They will welcome the FTC-led study, attention to AI integration, calls for prohibiting manipulative uses, protections for children and vulnerable populations, and the federal procurement constraints.
However, they will consider the measure only a first step and worry that a study and guidance alone are insufficient without binding privacy rights, enforceable private-sector rules, or stronger funding.
A centrist/technocratic persona would generally support the bill as a measured, evidence-gathering step that balances innovation with consumer protection.
They will view the FTC study, multiagency consultation, and OSTP/OMB-driven guidance as appropriate institutional channels to identify risks without immediately imposing heavy-handed regulation.
They will want clarity on costs, timing, how guidance will affect procurement and national security, and safeguards to avoid hindering legitimate medical or commercial innovation.
A mainstream conservative persona is likely to support a study of neural data as a matter of prudence, but will be skeptical of aspects that expand federal authority, impose binding procurement guidance, or risk constraining private-sector innovation and commercial freedom.
They will view OSTP/OMB binding implementation as a potential overreach that could become a de facto regulatory regime without Congress, and worry about costs and bureaucratic intrusion.
They will also be attentive to how guidance affects defense/national-security capabilities and whether exemptions are adequate.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Judged solely on content, the bill is modest in fiscal terms, largely administrative and study‑oriented, and contains compromise‑friendly features (consultation, phased implementation, emphasis on recommendations). These features increase its chances compared with sweeping regulatory overhauls. Key obstacles are competing legislative priorities and any concentrated industry opposition to future regulatory implications; however, because the bill does not itself impose binding rules on the private sector and primarily directs federal agencies to study and develop guidance, it falls into a category that historically has a reasonable chance of passage if given committee and floor time.
The bill has not accumulated any surfaced votes yet.
Scope and speed: Liberals view the bill as a needed first step toward strong protections; conservatives worry it will enable executive over…
Judged solely on content, the bill is modest in fiscal terms, largely administrative and study‑oriented, and contains compromise‑friendly f…
Relative to its intended legislative type, this bill establishes a detailed and well-scoped mandate for a comprehensive FTC-led study and reporting process on neural data governance and creates a clear, timebound path t…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.